TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) just unveiled an update.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced its intention to continue its H share repurchase plan, adjusting the maximum repurchase amount to HKD650 million due to the rising price of its H shares. The company believes that this move will demonstrate confidence in its business outlook and create value for shareholders, while maintaining a solid financial position. The repurchase is subject to regulatory approval in China and will be conducted at the discretion of the Board, depending on market conditions.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the medical technology industry, focusing on developing and providing advanced medical devices and solutions.
YTD Price Performance: 63.08%
Average Trading Volume: 141
Technical Sentiment Signal: Sell
Current Market Cap: €717.7M
See more data about 2190 stock on TipRanks’ Stock Analysis page.